Parameter | Cycle 1 (n (%))* | Cycle 2 (n (%))* | P value |
Patients | 56 | 58 | |
Mean age at initiation (years) | 29.3 (range 13–50) | 31.2 (range 15–44) | |
HIV seropositivity | 34 (73.9) | 23 (74.2) | |
Complete data available | 46 | 31 | |
Contraception started prior to referral for MDR-TB treatment | 11 (23.9)
| 12 (38.7)
| 0.1641† |
Contraception started at the time of MDR-TB treatment initiation | 0 (0%) | 12 (38.7)
| <0.0001† |
Total number of women who were on long-acting injectable contraceptives by the time their MDR-TB treatment was initiated | 11 (23.9) | 24 (77.4) | <0.0001† |
Pregnancy during treatment | 3 (6.5) | 0 (0) | 0.2690‡ |
*Or unit specified.
†Pearson’s Chi-squared test.
‡Fisher’s exact test.
DMPA, depot-medroxyprogesterone acetate; HIV, human immunodeficiency virus; MDR-TB, multidrug-resistant tuberculosis.